SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

BRIEF-Centogene Extends Global Parkinson’s Disease Study

05/10/2021 07:26
BRIEF-Centogene Extends Global Parkinson’s Disease Study

- Centogene NV 39K.MU:

  • CENTOGENE EXTENDS GLOBAL PARKINSON’S DISEASE STUDY

  • CENTOGENE NV - STUDY NOW AIMS TO RECRUIT AND GENETICALLY TEST AN ADDITIONAL 2,500 PATIENTS FOR PARKINSON'S

Source text for Eikon: ID:nGNX7yhG9P

Further company coverage: 39K.MU


(([email protected];))